The development of a quality assurance programme for HPV testing within the UK NHS cervical screening LBC/HPV studies

National Cervical Screening Committee LBC/HPV Pilot Steering Group, Heather A Cubie, Catherine Moore, Michael Waller, Sue Moss

Research output: Contribution to journalArticlepeer-review

Abstract

Cervical screening by cytology is effective but lacks sensitivity. The addition of human papillomavirus (HPV) testing can improve the effectiveness of screening for early identification of cervical disease. As HPV testing represents a new technology, a quality assurance (QA) programme is necessary to confirm the accuracy of results.
Original languageEnglish
Pages (from-to)287-92
Number of pages6
JournalJournal of Clinical Virology
Volume33
Issue number4
DOIs
Publication statusPublished - Aug 2005

Keywords

  • DNA, Viral
  • Female
  • Great Britain
  • Humans
  • Mass Screening
  • National Health Programs
  • Papillomaviridae
  • Papillomavirus Infections
  • Program Development
  • Quality Control
  • Reagent Kits, Diagnostic
  • Specimen Handling
  • Uterine Cervical Neoplasms
  • Vaginal Smears

Fingerprint

Dive into the research topics of 'The development of a quality assurance programme for HPV testing within the UK NHS cervical screening LBC/HPV studies'. Together they form a unique fingerprint.

Cite this